5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
52-week Open Label Safety-Tolerability StudySchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-09NCT07369154
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)depressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-08NCT07076407
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Focal, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsyRecruitingPhase 32026-09-02NCT07594119
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.bipolar I disorderRecruitingPhase 22026-07-27NCT07494305
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-07-27NCT07363577